for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
World News

Brazil's Butantan Institute will produce Sinovac vaccine even if excluded from national program

BRASILIA (Reuters) - Brazil’s Butantan Institute will manufacture 46 million doses of the COVID-19 vaccine developed by China’s Sinovac, which will be made available even if the vaccine is not included in the federal immunization program, director Dimas Covas said on Wednesday.

On Wednesday, President Jair Bolsonaro said Brazil will not buy vaccine from Sinovac, one day after the health minister said it would be included in the nation’s immunization program.

Reporting by Ricardo Brito, writing by Jake Spring; editing by Chris Reese

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up